Health Policy & Advocacy
Resources
Basic InformationMore InformationLatest News
Even Small Reductions in Air Pollution Help The HeartHigh Costs Lead Millions of Americans to Shop Abroad for Rx DrugsPandemic Hits Primary Care Practices Hard Across the U.S.: StudyOne-Time Treatment Eases Parkinson's -- in MiceAHA News: Here's What Doctors Know About Immunizations Right Now – You Still Need ThemDoctors' Choice of Anesthesia Could Help Curb Climate ChangeTough State Gun Laws Help Save Lives: StudyBlood Donors Will Get Results of Coronavirus Antibody Test, Red Cross SaysCOVID Got You Scared of Performing CPR? Study Finds Infection Risk Is LowFor Stressed-Out Black Americans, Mental Health Care Often Hard to Come ByHealthDay In-Depth
The AI Revolution: For Patients, Promise and Challenges Ahead">HealthDay In-Depth
The AI Revolution: For Patients, Promise and Challenges Ahead
Women Still Left Out of Much Medical ResearchHealthDay In-Depth
The AI Revolution: Robots Already Helping Humans Deliver Better Care">HealthDay In-Depth
The AI Revolution: Robots Already Helping Humans Deliver Better Care
HealthDay In-Depth
The AI Revolution: Giving Docs a Diagnostic Assist">HealthDay In-Depth
The AI Revolution: Giving Docs a Diagnostic Assist
AHA News: Calorie Data on Menus Could Generate Significant Health, Economic BenefitsPandemic Has Left Nearly 43 Million Americans Without WorkPeople Are Avoiding the ER During COVID-19 Crisis at Their Peril: StudyAs Postponed Surgeries Resume, Can U.S. Hospitals Handle the Strain?Most Americans Still More Worried About COVID-19 Spread Than the EconomyBig Need for Blood Donations as Postponed Surgeries ResumeEmergency Transport Can Surprise Many With Big BillsOnly Half of Americans Say They'd Get a Coronavirus Vaccine: SurveyIf Prescribed Opioids for Pain, Ask Lots of Questions: FDAState Texting Bans Are Saving Teen Drivers' LivesMillions of Older Americans Can't Get Enough FoodLayoffs and Losses: COVID-19 Leaves U.S. Hospitals in Financial CrisisFDA Goes After Unproven COVID-19 Antibody TestsDuring Droughts, Many Poor Americans Will Lack Clean Tap Water: StudyDid the Movie 'Joker' Reinforce Prejudice Against Mentally Ill?AHA News: How to Get the Most Out of Health AppsCoronavirus Conspiracy Theories Abound, and They Could Cause Real HarmAHA News: Health Emergency? Don't Hesitate to Get HelpAn Expert's Guide to Fact-Checking Coronavirus Info OnlineRacial, Ethnic Gaps in Insurance Put Moms, Babies at Risk: StudyCelebrity Suicides Spawn 'Copycat' Tragedies, Study ShowsVaccine Myths Widespread on the Web, Especially Facebook: Study
The Doctor Gap: In Areas of Greatest Need, Primary Care Is a Team Effort">
The Doctor Gap: In Areas of Greatest Need, Primary Care Is a Team Effort
The Doctor Gap: Where Are All the Mental Health Care Providers?New, Graphic Health Warnings Coming for U.S. Cigarette PacksWith New Boost From Medicare, 'Telemedicine' Steps Up to Fight CoronavirusThe Doctor Gap: In Rural America, It's All Hands on DeckThe Doctor Gap: A Training Program for Country-Doc WannabesDon't Believe All the 'Science' on CBD ProductsMany Car Crash Deaths Involve Alcohol Levels Below Legal Limit: StudyThe Doctor Gap: Does America Have a Physician Shortage?12 Weeks of Paid Maternity Leave Benefits Everyone: StudyVaping Videos Soaring on YouTubeU.S. Blood Donors Needed in Face of COVID-19 CrisisIt's Tough for Clinical Trial Participants to Learn ResultsBogus Coronavirus 'Meds' Targeted by FDA
Questions and AnswersVideosLinksBook Reviews
Related Topics

Health Insurance
Healthcare

Bogus Coronavirus 'Meds' Targeted by FDA

HealthDay News
by -- Robert Preidt
Updated: Mar 9th 2020

new article illustration

MONDAY, March 9, 2020 (HealthDay News) -- U.S. officials are cracking down on companies selling fraudulent products that claim to prevent or treat the new coronavirus.

Seven companies -- whose goods range from essential oils to colloidal silver -- were sent warning letters from the U.S. Food and Drug Administration and the U.S. Federal Trade Commission, the FDA said Monday.

"The FDA considers the sale and promotion of fraudulent COVID-19 products to be a threat to the public health," FDA Commissioner Dr. Stephen Hahn said in an agency news release.

"We have an aggressive surveillance program that routinely monitors online sources for health fraud products, especially during a significant public health issue such as this one," he added.

Currently, there are no vaccines or drugs approved to treat or prevent COVID-19, the FDA said.

The warning letters were sent to: Vital Silver; Quinessence Aromatherapy Ltd.; Xephyr LLC doing business as N-Ergetics; GuruNanda, LLC; Vivify Holistic Clinic; Herbal Amy LLC, and The Jim Bakker Show.

Besides essential oils and colloidal silver, the products in question include teas and tinctures. These unapproved drugs pose significant health risks and violate federal law, the FDA noted.

Colloidal silver isn't safe or effective for treating any condition, the FDA has said in the past.

Products that falsely claim to cure, treat or prevent serious diseases like COVID-19 may lead people to delay or stop appropriate medical treatment, resulting in serious and life-threatening harm, the FDA warned.

"We understand consumers are concerned about the spread of COVID-19 and urge them to talk to their health care providers, as well as follow advice from other federal agencies about how to prevent the spread of this illness. We will continue to aggressively pursue those that place the public health at risk and hold bad actors accountable," Hahn said.

Since the outbreak of COVID-19 reached the United States, some consumers have also faced much higher-than-normal prices for products such as face masks, hand sanitizers and disinfectant wipes.

Online sales of virus protection products have spiked 817% in the last two months, and prices have skyrocketed, CBS News reported.

There is a high level of anxiety over the potential spread of coronavirus, said Joe Simons, FTC chair.

"What we don't need in this situation are companies preying on consumers by promoting products with fraudulent prevention and treatment claims. These warning letters are just the first step. We're prepared to take enforcement actions against companies that continue to market this type of scam," Simons added.

The companies that received the warning letters have 48 hours to outline steps taken to correct the violations. Companies selling products that falsely claim to prevent, treat or cure COVID-19 may face legal action, including seizure or injunction.

The FDA and FTC also said they'll continue to monitor social media, online marketplaces and complaints to help ensure that the companies do not continue to sell bogus products under a different company name or on another website.

The FDA has created a cross-agency task force to closely monitor for fraudulent products related to COVID-19.

More information

The U.S. Centers for Disease Control and Prevention has more on COVID-19.




Facebook

Amazon Smile

 

Children and Adult services are available now with no wait time.  

Please contact HBH at 860-548-0101, option 2.

 


powered by centersite dot net